34 Participants Needed

Lifestyle Changes for Prediabetes

LB
MS
LN
Overseen ByLena Navarro
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial excludes participants who are on medications that affect insulin sensitivity, glucose concentrations, and body weight, so you may need to stop taking such medications to participate.

What data supports the effectiveness of the treatment for prediabetes?

Research shows that maintaining a consistent sleep pattern and making lifestyle changes can help control blood sugar levels in people with prediabetes. Studies have found that irregular sleep and short sleep duration are linked to a higher risk of developing diabetes, while structured lifestyle interventions can improve glucose metabolism.12345

Is the lifestyle intervention for prediabetes safe for humans?

The studies suggest that lifestyle interventions, including those focusing on sleep and consistent daily routines, are generally safe for humans. These interventions have been tested in various groups, including people with prediabetes and those living with HIV, without significant safety concerns reported.13467

How is the Fixed Schedule, Fixed Sleep treatment for prediabetes different from other treatments?

This treatment focuses on maintaining a consistent sleep schedule, which is unique because irregular sleep is linked to poor glucose metabolism. Unlike other treatments that may focus solely on diet and exercise, this approach emphasizes stable sleep patterns as a key component of managing prediabetes.35789

What is the purpose of this trial?

The goal of the proposed study is to evaluate the feasibility and initial efficacy of stabilizing lifestyle behaviors to improve glucose control and body composition in patients with pre-diabetes.The investigator proposes that following stable lifestyle behaviors will improve patients' glucose control, body composition, and liver fat. The results from this study has the potential to impact clinical practice and patient care.

Research Team

BL

Blandine Laferrere

Principal Investigator

Columbia University

MS

Marie-Pierre St-Onge

Principal Investigator

Columbia University

Eligibility Criteria

This trial is for adults aged 35 or older with prediabetes, defined by specific blood sugar levels (hemoglobin A1c between 5.7-6.4%). Participants should have a BMI of 25-39.9 and sleep at least 6 hours nightly. Excluded are those with cardiovascular disease, certain kidney conditions, sleep apnea, recent weight loss programs, severe lipid problems, shift workers, substance abuse history, uncontrolled high blood pressure or psychiatric disorders.

Inclusion Criteria

Your body mass index (BMI) is between 25 and 39.9.
You sleep for at least 6 hours every night, as measured by a special wrist device for 14 nights.
My A1c levels are between 5.7% and 6.4%, indicating pre-diabetes.
See 2 more

Exclusion Criteria

I have been diagnosed with obstructive sleep apnea.
I have a psychiatric or neurological condition.
I can travel across different time zones.
See 8 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2 weeks
1 visit (in-person)

Baseline Assessment

Participants track their sleep and wear a glucose monitor to measure glucose levels

2 weeks
1 visit (in-person)

Treatment

Participants are randomized to either maintain usual habits or stabilize lifestyle behaviors

12 weeks
2 visits (in-person) at start and end

Follow-up

Participants are monitored for changes in glucose control, body composition, and liver fat

4 weeks

Treatment Details

Interventions

  • Fixed Schedule
  • Fixed Sleep
Trial Overview The study tests whether having a fixed schedule for daily activities can improve blood sugar control and body composition in people with prediabetes. It aims to see if stable lifestyle patterns reduce liver fat and help manage glucose levels better than variable lifestyles.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Fixed ScheduleExperimental Treatment1 Intervention
Participants randomized to Fixed Schedule (FS) will be asked to stabilize their lifestyle behaviors for 12 weeks.
Group II: Variable ScheduleActive Control1 Intervention
Participants randomized to Variable Schedule (VS) will be asked to maintain their usual habits for 12 weeks.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+

Department of Health and Human Services

Collaborator

Trials
240
Recruited
944,000+

Findings from Research

Collaboration between sleep/circadian researchers and metabolism/diabetes experts is essential to translate basic research findings into practical strategies for improving metabolic health, particularly in the context of sleep disruption.
There is a significant opportunity to explore the effects of CPAP treatment for obstructive sleep apnea on pre-diabetes and the impact of temporal restricted feeding on obesity, which could lead to new preventative measures against diabetes.
Impact of Sleep and Circadian Disruption on Energy Balance and Diabetes: A Summary of Workshop Discussions.Arble, DM., Bass, J., Behn, CD., et al.[2022]
In a study of 522 overweight individuals with impaired glucose tolerance, long sleep duration (9-10 hours or more) was linked to a higher risk of developing type 2 diabetes, particularly in those who did not receive lifestyle intervention.
However, participants who underwent lifestyle interventions, including diet and exercise, did not show an increased diabetes risk associated with long sleep duration, suggesting that such interventions can mitigate the negative effects of excessive sleep on diabetes risk.
Sleep duration, lifestyle intervention, and incidence of type 2 diabetes in impaired glucose tolerance: The Finnish Diabetes Prevention Study.Tuomilehto, H., Peltonen, M., Partinen, M., et al.[2022]
A pilot six-month intensive lifestyle intervention (ILI) program for people living with HIV and prediabetes led to significant weight loss and waist circumference reduction, indicating its effectiveness in improving metabolic control.
Increased sleep variability was linked to higher plasma glucose levels, suggesting that sleep patterns may influence the metabolic outcomes of the ILI program, highlighting the need for further research in larger studies.
Effects of an intensive lifestyle intervention and the role of sleep in people living with HIV and prediabetes: a pilot and feasibility study.Nimitphong, H., Sungkanuparph, S., Areevut, C., et al.[2021]

References

Impact of Sleep and Circadian Disruption on Energy Balance and Diabetes: A Summary of Workshop Discussions. [2022]
Sleep duration, lifestyle intervention, and incidence of type 2 diabetes in impaired glucose tolerance: The Finnish Diabetes Prevention Study. [2022]
Effects of an intensive lifestyle intervention and the role of sleep in people living with HIV and prediabetes: a pilot and feasibility study. [2021]
The association between rest-activity parameters and hemoglobin A1c in patients with prediabetes. [2023]
Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) Study: design of lifestyle intervention. [2022]
Preventing Type 2 Diabetes Among Midlife Women: A Feasibility Study Comparing a Combined Sleep and Lifestyle Intervention With a Standard Lifestyle Intervention. [2021]
The Relationship Between Dietary Patterns and Glycemic Variability in People with Impaired Glucose Tolerance. [2023]
Impact of an augmented intervention on self-regulatory, dietary and physical activity outcomes in a diabetes prevention trial among adults with prediabetes. [2023]
Does the Effect of a 3-Year Lifestyle Intervention on Body Weight and Cardiometabolic Health Differ by Prediabetes Metabolic Phenotype? A Post Hoc Analysis of the PREVIEW Study. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity